Emerging in the field of obesity treatment, retatrutide presents a unique strategy. Unlike many current medications, retatrutide functions as a dual agonist, simultaneously targeting both glucagon-like peptide-1 https://mattiexbxe972747.develop-blog.com/46295943/this-novel-retatrutide-a-glp-gip-receptor-agonist